Cargando…

Benzimidazole scaffolds as promising antiproliferative agents: a review

Cancer is one of the most serious medical problem and second leading cause of death in the world, characterized by a deregulation of the cell cycle which mainly results in a progressive loss of cellular differentiation and uncontrolled cellular growth. The benzimidazole is a heterocyclic moiety foun...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahlan, Sumit, Kumar, Sanjiv, Kakkar, Saloni, Narasimhan, Balasubramanian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661752/
https://www.ncbi.nlm.nih.gov/pubmed/31384813
http://dx.doi.org/10.1186/s13065-019-0579-6
_version_ 1783439517693247488
author Tahlan, Sumit
Kumar, Sanjiv
Kakkar, Saloni
Narasimhan, Balasubramanian
author_facet Tahlan, Sumit
Kumar, Sanjiv
Kakkar, Saloni
Narasimhan, Balasubramanian
author_sort Tahlan, Sumit
collection PubMed
description Cancer is one of the most serious medical problem and second leading cause of death in the world, characterized by a deregulation of the cell cycle which mainly results in a progressive loss of cellular differentiation and uncontrolled cellular growth. The benzimidazole is a heterocyclic moiety found in extensive number of natural and biological active molecules. Benzimidazole derivatives might be considered as auxiliary isosters of nucleotides having attached heterocyclic cores in their structures, cooperate effortlessly with biopolymers and have potential action for chemotherapeutic applications. Benzimidazole and its derivatives displayed a wide range of biological activity because of its structural similarity with the naturally occurring nucleotides. Benzimidazole has established huge alertness in current time and is extremely significant heterocyclic pharmacophore in recent drug innovation and medicinal chemistry. The present review summarizes the chemistry of various substituted benzimidazole derivatives with their antiproliferative significance towards the various cancer cell lines such as HCT116, MCF7, HeLa, HepG2, A549 and A431. [Image: see text]
format Online
Article
Text
id pubmed-6661752
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-66617522019-08-05 Benzimidazole scaffolds as promising antiproliferative agents: a review Tahlan, Sumit Kumar, Sanjiv Kakkar, Saloni Narasimhan, Balasubramanian BMC Chem Review Cancer is one of the most serious medical problem and second leading cause of death in the world, characterized by a deregulation of the cell cycle which mainly results in a progressive loss of cellular differentiation and uncontrolled cellular growth. The benzimidazole is a heterocyclic moiety found in extensive number of natural and biological active molecules. Benzimidazole derivatives might be considered as auxiliary isosters of nucleotides having attached heterocyclic cores in their structures, cooperate effortlessly with biopolymers and have potential action for chemotherapeutic applications. Benzimidazole and its derivatives displayed a wide range of biological activity because of its structural similarity with the naturally occurring nucleotides. Benzimidazole has established huge alertness in current time and is extremely significant heterocyclic pharmacophore in recent drug innovation and medicinal chemistry. The present review summarizes the chemistry of various substituted benzimidazole derivatives with their antiproliferative significance towards the various cancer cell lines such as HCT116, MCF7, HeLa, HepG2, A549 and A431. [Image: see text] Springer International Publishing 2019-05-15 /pmc/articles/PMC6661752/ /pubmed/31384813 http://dx.doi.org/10.1186/s13065-019-0579-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Tahlan, Sumit
Kumar, Sanjiv
Kakkar, Saloni
Narasimhan, Balasubramanian
Benzimidazole scaffolds as promising antiproliferative agents: a review
title Benzimidazole scaffolds as promising antiproliferative agents: a review
title_full Benzimidazole scaffolds as promising antiproliferative agents: a review
title_fullStr Benzimidazole scaffolds as promising antiproliferative agents: a review
title_full_unstemmed Benzimidazole scaffolds as promising antiproliferative agents: a review
title_short Benzimidazole scaffolds as promising antiproliferative agents: a review
title_sort benzimidazole scaffolds as promising antiproliferative agents: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661752/
https://www.ncbi.nlm.nih.gov/pubmed/31384813
http://dx.doi.org/10.1186/s13065-019-0579-6
work_keys_str_mv AT tahlansumit benzimidazolescaffoldsaspromisingantiproliferativeagentsareview
AT kumarsanjiv benzimidazolescaffoldsaspromisingantiproliferativeagentsareview
AT kakkarsaloni benzimidazolescaffoldsaspromisingantiproliferativeagentsareview
AT narasimhanbalasubramanian benzimidazolescaffoldsaspromisingantiproliferativeagentsareview